PT1051155E - Solucoes nasais - Google Patents

Solucoes nasais

Info

Publication number
PT1051155E
PT1051155E PT99904823T PT99904823T PT1051155E PT 1051155 E PT1051155 E PT 1051155E PT 99904823 T PT99904823 T PT 99904823T PT 99904823 T PT99904823 T PT 99904823T PT 1051155 E PT1051155 E PT 1051155E
Authority
PT
Portugal
Prior art keywords
nasa
solutions
liquid
nasal
inter alia
Prior art date
Application number
PT99904823T
Other languages
English (en)
Inventor
Matthias Seidel
Christopher Buckley
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of PT1051155E publication Critical patent/PT1051155E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99904823T 1998-01-30 1999-01-28 Solucoes nasais PT1051155E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98810069 1998-01-30

Publications (1)

Publication Number Publication Date
PT1051155E true PT1051155E (pt) 2002-10-31

Family

ID=8235913

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99904823T PT1051155E (pt) 1998-01-30 1999-01-28 Solucoes nasais

Country Status (12)

Country Link
EP (1) EP1051155B1 (pt)
JP (1) JP4603687B2 (pt)
AT (1) ATE219657T1 (pt)
AU (1) AU741364B2 (pt)
CA (1) CA2311530C (pt)
DE (1) DE69901936T2 (pt)
DK (1) DK1051155T3 (pt)
ES (1) ES2180274T3 (pt)
IL (1) IL136591A (pt)
NZ (1) NZ505919A (pt)
PT (1) PT1051155E (pt)
WO (1) WO1999038492A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
ATE232099T1 (de) * 1999-06-22 2003-02-15 Boehringer Ingelheim Int Stabile xylometazolin- und oxymetazolinlösung
HU226527B1 (hu) * 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére
BG65734B1 (bg) * 2002-02-22 2009-09-30 Био Терапютикс - Еоод Течен мукоадхезивен фармацевтичен състав
NZ537186A (en) * 2002-06-20 2006-10-27 Novartis Consumer Health S Nasal compositions comprising a mucopolysaccharide and propylene glycol
US7714011B2 (en) 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
CA2530531A1 (en) 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
JP4956981B2 (ja) * 2005-01-05 2012-06-20 大正製薬株式会社 オキシメタゾリン含有水性組成物
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US8940796B2 (en) 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
DE102008007198A1 (de) * 2008-02-01 2009-08-13 Infectopharm Arzneimittel Und Consilium Gmbh Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
US20120022032A1 (en) * 2008-10-10 2012-01-26 Schering Corporation Corticosteroid compositions and methods of treatments thereof
PL2759290T3 (pl) 2013-01-24 2020-03-31 Merz Pharma Gmbh & Co. Kgaa Płynny preparat w aerozolu do stosowania donosowego z wydłużonym miejscowym czasem działania
DE102013001151A1 (de) 2013-01-24 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
DE202013000748U1 (de) 2013-01-24 2013-02-19 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
US20160120990A1 (en) 2013-07-17 2016-05-05 Dow Global Technologies Llc Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
US20160228559A1 (en) * 2013-09-25 2016-08-11 Dow Global Technologies Llc Composition for application to a mucosa comprising a cellulose ether
CA2972177A1 (en) * 2014-12-24 2016-06-30 Jadran - Galenski Laboratorij D.D. A nasal composition containing sea water as stability-improving excipient
WO2018195029A1 (en) * 2017-04-17 2018-10-25 Insys Development Company, Inc. Epinephrine spray formulations
EP3806827A4 (en) * 2018-06-13 2022-03-23 Hikma Pharmaceuticals USA Inc. EPINEPHRINE SPRAY FORMULATIONS
CA3110773C (en) 2018-09-11 2023-02-28 Lead Biotherapeutics Ltd. Mucoadhesive dispersion nanoparticle system and method for production the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH04327533A (ja) * 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
EP0571671B1 (en) * 1992-05-26 1997-09-17 The Procter & Gamble Company A Pharmaceutical composition in powder form
CA2101126A1 (en) * 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
PT689438E (pt) * 1993-03-26 2003-10-31 Franciscus Wilhelmus He Merkus Composicoes farmaceuticas para administracao intranasal de apomorfina
JPH07109228A (ja) * 1993-10-08 1995-04-25 Earth Chem Corp Ltd リゾチーム配合口腔用組成物
EP0689843B1 (en) * 1993-12-17 2003-09-10 Mochida Pharmaceutical Co., Ltd. Composition containing soluble thrombomodulins
JP3269770B2 (ja) * 1995-03-02 2002-04-02 参天製薬株式会社 再分散性の優れたイオン性高分子配合水性懸濁点眼剤
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
EP1020194A4 (en) * 1997-10-01 2003-05-21 Wakamoto Pharma Co Ltd OIL / WATER EMULSION COMPILATIONS

Also Published As

Publication number Publication date
ATE219657T1 (de) 2002-07-15
AU2519899A (en) 1999-08-16
DE69901936T2 (de) 2002-11-28
EP1051155A1 (en) 2000-11-15
CA2311530C (en) 2008-06-10
CA2311530A1 (en) 1999-08-05
JP4603687B2 (ja) 2010-12-22
JP2002501884A (ja) 2002-01-22
EP1051155B1 (en) 2002-06-26
NZ505919A (en) 2002-10-25
IL136591A0 (en) 2001-06-14
ES2180274T3 (es) 2003-02-01
DK1051155T3 (da) 2002-09-16
IL136591A (en) 2005-08-31
DE69901936D1 (de) 2002-08-01
WO1999038492A1 (en) 1999-08-05
AU741364B2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
PT1051155E (pt) Solucoes nasais
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
ES2162951T3 (es) Estabilizacion de composiciones de prostaglandina.
NO970051L (no) Vandige risperidon formuleringer
BR9902086A (pt) Formulações farmacêuticas.
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
SE9200951D0 (sv) Pharmaceutical composition containing a defined lipid system
DE60108236D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
AU3227700A (en) Skin sanitizing compositions
BR0014355A (pt) Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
HUP0101498A1 (hu) Dexmedetomidin alkalmazása nyugtató hatású gyógyszerkészítmények előállítására
BR0114912A (pt) Kahalalide f
SE9801494D0 (sv) Novel use
DE69911388D1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DK1092431T3 (da) Lasofoxifenpræparater
NO20014081L (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
MD1473G2 (ro) Remediu antiherpetic
ATE241640T1 (de) Fusidinsäure-derivate
TNSN03036A1 (en) Stabilized brivudine topical formulations
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
MXPA03010821A (es) Composiciones de aroma y fragancias.
BR0213463A (pt) Composições farmacêuticas contendo macrólidos